Fibroblast Growth Factor 23: Potential Marker of Invisible Heart Damage in Diabetic Population
-
Published:2023-05-25
Issue:6
Volume:11
Page:1523
-
ISSN:2227-9059
-
Container-title:Biomedicines
-
language:en
-
Short-container-title:Biomedicines
Author:
Kurpas Anna1ORCID, Supel Karolina1ORCID, Wieczorkiewicz Paulina1ORCID, Bodalska Duleba Joanna2, Zielinska Marzenna1ORCID
Affiliation:
1. Department of Interventional Cardiology, Medical University of Lodz, 251 Pomorska Street, 92-213 Lodz, Poland 2. Diabetes Outpatient Clinic ‘Poradnia Nowa’, 90-631 Lodz, Poland
Abstract
Two-dimensional speckle-tracking echocardiography (2DSTE) detects myocardial dysfunction despite a preserved left ventricular ejection fraction. Fibroblast growth factor 23 (FGF23) has become a promising biomarker of cardiovascular risk. This study aimed to determine whether FGF23 may be used as a marker of myocardial damage among patients with diabetes mellitus type 2 (T2DM) and no previous history of myocardial infarction. The study enrolled 71 patients with a median age of 70 years. Laboratory data were analyzed retrospectively. Serum FGF23 levels were determined using a sandwich enzyme-linked immunosorbent assay. All patients underwent conventional echocardiography and 2DSTE. Baseline characteristics indicated that the median time elapsed since diagnosis with T2DM was 19 years. All subjects were divided into two groups according to left ventricular diastolic function. Individuals with confirmed left ventricular diastolic dysfunction had significantly lower levels of estimated glomerular filtration rate and higher values of hemoglobin A1c. Global circumferential strain (GCS) was reduced in the majority of patients. Only an epicardial GCS correlated significantly with the FGF23 concentration in all patients. The study indicates that a cardiac strain is a reliable tool for a subtle myocardial damage assessment. It is possible that FGF23 may become an early diagnostic marker of myocardial damage in patients with T2DM.
Funder
Medical University of Lodz
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference66 articles.
1. Magliano, D.J., and Boyko, E.J. (2023, January 10). Chapter 3, Global Picture, IDF Diabetes Atlas 10th Edition Scientific Committee, Available online: https://www.ncbi.nlm.nih.gov/books/NBK581940/. 2. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications;Zheng;Nat. Rev. Endocrinol.,2018 3. Impact of diabetes on cardiovascular disease: An update;Tannus;Int. J. Hypertens.,2013 4. Emerging Risk Factors Collaboration, Sarwar, N., Gao, P., Seshasai, S.R., Gobin, R., Kaptoge, S., Di Angelantonio, E., Ingelsson, E., Lawlor, D.A., and Selvin, E. (2010). Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet, 375, 2215–2222. Erratum in Lancet 2010, 376, 958. Hillage, H L [corrected to Hillege, H L]. 5. Congestive heart failure in type 2 diabetes: Prevalence, incidence, and risk factors;Nichols;Diabetes Care,2001
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|